Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CRMD - CorMedix hires new CEO makes other executive changes; new operational focus

CRMD - CorMedix hires new CEO makes other executive changes; new operational focus

CorMedix Inc.
CorMedix (NASDAQ:CRMD) hired Joe Todisco as its new CEO, effective May 10. The infectious and inflammatory diseases developer also said that Chief Commercial Officer Tom Nusbickel has left. Donna Ucci joined the Company as SVP and head of global quality. Liz Hurlburt, EVP of clinical operations, was promoted to EVP of clinical & medical affairs. CorMedix will wind down European operations and end the sales of Neutrolin, a solution to prevent catheter-related blood stream infections, there. The company will focus on NDA approval and commercialization of Neutrolin in the U.S., where it is known as DefenCath. CorMedix reports Q1 2022 results after market close Thursday.

For further details see:

CorMedix hires new CEO, makes other executive changes; new operational focus
Stock Information
Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com
Menu
CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...